Search
Search Results
##search.searchResults.foundPlural##
-
-
-
PREVALENCE OF HEPATITIS B, HEPATITIS C AND HIV IN MULTIPLY TRANSFUSED SICKLE CELL DISEASE PATIENTS FROM OMAN HBV,HCV and HIV and Sickle Cell Disease.
1516PDF: 954HTML: 337 -
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus
2605PDF: 955HTML: 2151 -
APPROPRIATE DURATION OF INTRAVENOUS TREATMENT OF CANDIDEMIA AND TIMING OF STEP DOWN TO ORAL THERAPY IN NON-NEUTROPENIC PATIENTS
2691PDF: 884HTML: 339Preferred Reviewers: 186 -
A NEGLECTED ZOONOSIS IN ALBANIA: WHY ECHINOCOCCOSIS IS BECOMING A SURGEON’S EXCLUSIVITY?
1501PDF: 800HTML: 3765Cover letter: 202Title page: 204Figure 1: 134 -
CEREBRAL VENOUS THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2457PDF: 918HTML: 2211 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7181PDF: 2344HTML: 1699Table 1.: 181Table 2.: 197Table 3.: 179Table 4.: 177 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4110PDF: 1485HTML: 420 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1253PDF: 1077HTML: 88 -
The diagnostic pitfalls of mucormycosis
814PDF: 687HTML: 223 -
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1943PDF: 772HTML: 194 -
SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
2870PDF: 692HTML: 1099Cover Letter: 178 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1958PDF: 1572HTML: 344 -
LIMITED STAGE FOLLICULAR LYMPHOMA: THE ROLE OF RADIATION THERAPY.
3621PDF: 1042HTML: 2254Figure 1: 192 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
376PDF: 196HTML: 70 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1335PDF: 1002HTML: 205 -
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
1752PDF: 686HTML: 2082Untitled: 186Untitled: 137Untitled: 151Untitled: 138Untitled: 144Untitled: 160Untitled: 166 -
MOLECULAR PATHOGENESIS OF SECONDARY ACUTE PROMYELOCYTIC LEUKEMIA
2705PDF: 810HTML: 6491Untitled: 204Untitled: 167Untitled: 163Untitled: 186 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3162PDF: 1907HTML: 7450 -
-
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
1934PDF: 1803HTML: 324 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3754PDF: 1401HTML: 8482 -
HEMATOPOIETIC STEM CELL TRNSPLANTATION IN THALASSEMIA AND RELATED DISORDERS
1344PDF: 473HTML: 3939 -
CHRONIC MYELOGENOUS LEUKEMIA (CML) IN THE ELDERLY
2829PDF: 1063HTML: 3013 -
NEW THERAPEUTIC OPTIONS FOR THE TREATMENT OF SICKLE CELL DISEASE Guest Editor: Raffaella Origa
6632PDF: 3531HTML: 717







